Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
Ahmed M I Elfiky(GlaxoSmithKline (United Kingdom)), Wouter J. de Jonge(University of Bonn), Juan J. García‐Vallejo(Amsterdam UMC Location Vrije Universiteit Amsterdam), Rab K. Prinjha(GlaxoSmithKline (United Kingdom)), Rebecca C. Furze(Age UK), Manon E. Wildenberg(Amsterdam UMC Location University of Amsterdam), Olaf Welting(Amsterdam UMC Location University of Amsterdam), Huw D. Lewis(MSD (UK) Limited (United Kingdom)), Iris Admiraal(Amsterdam University Medical Centers), Sigrid E.M. Heinsbroek(Amsterdam UMC Location University of Amsterdam), Jan Verhoeff, Laura Tomlinson(Age UK), Inmaculada Rioja(Bicycle Therapeutics (United Kingdom)), Shafaque Rahman(Amsterdam University Medical Centers), Mohammed Ghiboub(Amsterdam UMC Location University of Amsterdam), Palwinder K. Mander(Age UK), Andrew Y. F. Li Yim(Amsterdam University Medical Centers), Patricia H. P. van Hamersveld, Richard Gregory(Age UK), Matthew Bell(GlaxoSmithKline (United Kingdom)), Ishtu Hageman(Amsterdam University Medical Centers), Manon de Krijger(Amsterdam University Medical Centers)
Cited by 15
Related Papers
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
|British Journal of Pharmacology|2007|634
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|Human Molecular Genetics|2008|479
Neuroimmune mechanisms in postoperative ileus
|Gut|2009|362